Connect with us
[the_ad id="89560"]

Business

From ‘brilliant’ to ‘aghast’: Reactions to RFK Jr.’s nomination for HHS secretary run the gamut

Published

12 minute read

From LifeSiteNews

By Dr. Brenda Baletti, The Defender

From “brilliant” to “aghast” – President-elect Donald J. Trump’s nomination on Thursday of Robert F. Kennedy Jr., founder of Children’s Health Defense (CHD), to run the U.S. Department of Health and Human Services (HHS) triggered a range of reactions among media outlets, public health officials, and Kennedy’s long-time supporters and detractors.

In a statement posted on Truth Social and X, Trump said Kennedy would restore the public health agencies “to the traditions of Gold Standard Scientific Research, and beacons of Transparency, to end the Chronic Disease epidemic, and to Make America Great and Healthy Again!”

Kennedy, who promised to fight corruption and end the revolving door between industry and government, thanked Trump for the nomination on social media. He said he would “free the agencies from the smothering cloud of corporate capture so they can pursue their mission to make Americans once again the healthiest people on Earth.”

 

Kennedy is a longtime critic of how corporate interests have captured the public health agencies meant to regulate them, and of the outsized and corrupt role that Big Pharma plays in American life.

If confirmed, Kennedy would hold the most powerful governmental position in public health, overseeing 80,000 employees across a department that houses 13 agencies and more than 100 programs. Those agencies include the Centers for Disease Control and Prevention (CDC), the U.S. Food and Drug Administration (FDA), the National Institutes of Health and the Center for Medicaid and Medicare Services.

CHD CEO Mary Holland told The Defender the organization “could not be more pleased” with the nomination, adding:

Kennedy has been devoted to ending the childhood chronic health epidemic for almost 20 years. He has been effective in communicating the failures of our existing public health establishment.

Based on his extensive litigation history, he is uniquely prepared to reform the regulatory institutions, the research institutions, and public education on health. I look forward to seeing dramatic, measurable improvements in Americans’ health during the Trump administration.

Democratic Colorado Gov. Jared Polis said on X that he was “excited by the news,” particularly about Kennedy’s commitment to fighting chemicals in foods, the power of Big Pharma, and to other health priorities.

“I hope he leans into personal choice on vaccines rather than bans (which I think are terrible, just like mandates) but what I’m most optimistic about is taking on big pharma and the corporate ag oligopoly to improve our health,” he added.

Rep. Chip Roy (R-Texas) told Fox News, “I think Robert is another disruptor. We need a disruptor. I will be glad and I’m looking forward to working with him,” Politico reported.

Sen. Ron Johnson (R-Wis.) called Kennedy a “brilliant, courageous truth-teller” and said he could make the “most significant impact on health.”

Vaccine stocks take a dive on news of announcement

On the flip side, some lawmakers and public health leaders expressed alarm, decrying the nomination.

U.S. Rep. Robert Garcia (D-Calif.) called the choice “f— insane” on X, Fox News reported. “He’s a vaccine denier and a tin foil hat conspiracy theorist. He will destroy our public health infrastructure and our vaccine distribution systems. This is going to cost lives.”

Dr. Richard E. Besser, CEO of the Robert Wood Johnson Foundation and a former acting director of the CDC, said that having Kennedy head up HHS “would pose incredible risks to the health of the nation,” because Kennedy’s critique of the public health agencies was worsening the mistrust lingering after the coronavirus pandemic, The New York Times reported.

Besser told CNN that some of Kennedy’s ideas about chronic health issues regarding children were good ideas, but other ideas were deeply concerning – particularly Kennedy’s proposal that individuals should decide for themselves whether to take a vaccine.

“The idea that receiving childhood vaccines would be a parental choice scares me,” he said.

READ: Canada’s public health agency still working to adopt WHO pandemic treaty: report

Current CDC Director Mandy Cohen raised concerns that Kennedy would use the position to spread misinformation and foster distrust in public health institutions, particularly with respect to vaccines.

Kennedy has called for an end to immunity for vaccine manufacturers for the injuries caused by their products. He points out that no vaccine on the childhood immunization schedule has undergone proper safety and efficacy testing.

He has been a long-term advocate for the tens of thousands of families seeking compensation for their children’s vaccine-induced autism.

Kennedy also promised that, if confirmed, he would make the V-safe vaccine injury data collected but not made public by the CDC transparent, so scientists have access to the data necessary to analyze vaccine safety

Vaccine and Pharma stocks fell sharply this morning, following yesterday’s announcement about Kennedy, Reuters reported.

 

Bavarian Nordic, which makes the mpox vaccine, was down 16 percent. Its CEO told Reuters he was concerned that Kennedy could fuel vaccine skepticism.

However, he also said that the U.S. response to the COVID-19 pandemic under Trump’s first term made him confident that the incoming administration would continue to fund biodefense.

The Trump administration launched and oversaw Operation Warp Speed, the public-private partnership to rapidly develop a COVID-19 vaccine that gave vaccine makers hundreds of billions in profits along with total immunity for any harms caused by those investigational vaccines under the Public Readiness and Emergency Preparedness (PREP) Act.

Kennedy will be ‘single greatest threat to profits in America’

Republican advisers have cautioned that Kennedy could face a difficult path to confirmation, The Washington Post reported, citing his “past statements on drugs and vaccines, and his many personal entanglements.” FiercePharma said his confirmation process is likely “to be contentious.”

Physician, professor and Substacker Dr. Vinay Prasad wrote that Trump could use a recess appointment to secure Kennedy’s position, but that he will likely need to be confirmed by the Senate where “He has a several hundred billion dollar industry that will do everything possible to stop him.”

“Many of these companies have lobbied throughout Congress,” Prasad added. “They will use those connections. Unlike other controversial appointees, RFK Jr. will be the single greatest threat to profits in America.”

If his appointment goes through, Prasad said Kennedy will face a difficult road in getting his proposed policies enacted, given the entrenched power of Pharma and the power of the media that opposes him.

Law professor Wendy Parmet, director of Northeastern University’s Center for Health Policy and Law, pointed to the potential clash between Kennedy’s anti-industry position and the big-business leanings of the Republican Party.

“We have an administration that promises to deregulate, to be business-friendly, and then we have RFK Jr., who promises to go after fast food,” Parmet told The Washington Post.

READ: Idaho health district votes to stop offering COVID vaccines at its medical centers

Health and health freedom advocates optimistic Kennedy will bring change

Despite the challenges ahead, health advocates are optimistic that changes they have been seeking for decades will come to pass.

During the COVID-19 pandemic, critics of pandemic policies were condemned and marginalized. Kennedy was censored by the Biden administration and social media companies as part of the so-called “Disinformation Dozen” for airing many of those critiques.

Over the course of the election Kennedy – who ran for president as a Democrat, then announced he was running as an independent before suspending his campaign and endorsing Trump – has repeatedly been called a “conspiracy theorist.” Both Kennedy and CHD are routinely dismissed as “anti-vax” for openly discussing the scientific evidence on the link between vaccines and chronic diseases including autism, attention-deficit/hyperactivity disorder or ADHD and other neuropsychiatric and autoimmune disorders, in some children.

Rather than investigating the science, mainstream media mostly insists these links have been “debunked,” without providing any evidence for their claim.

Kennedy has also called for the removal of fluoride from public drinking water, citing recent studies and a landmark federal court decision that show it interferes with children’s brain development – a concern that has even been flagged by some mainstream public health commentators.

His supporters hope these issues will now receive serious public attention that will lead to policy change.

Holland said on X that Kennedy’s nomination came 38 years to the day after the Vaccine Injury Act that gave vaccine manufacturers immunity from liability was signed into law.

Let’s rewrite this one,” she said.

Business

DOJ drops Biden-era discrimination lawsuit against Elon Musk’s SpaceX

Published on

MXM logo  MxM News

Quick Hit:

The Justice Department has withdrawn a discrimination lawsuit against Elon Musk’s SpaceX that was filed during the Biden administration. The lawsuit accused SpaceX of discriminatory hiring practices against asylum seekers and refugees. The move follows ongoing cost-cutting measures led by Musk as the head of the Department of Government Efficiency under the 47th President Donald Trump’s administration.

Key Details:

  • The DOJ filed an unopposed motion in Texas federal court to lift a stay on the case, signaling its intent to formally dismiss the lawsuit.

  • The lawsuit, filed in 2023, alleged SpaceX required job applicants to be U.S. citizens or permanent residents, a restriction prosecutors argued was unlawful for many positions.

  • Elon Musk criticized the lawsuit as politically motivated, asserting that SpaceX was advised hiring non-permanent residents would violate international arms trafficking laws.

Diving Deeper:

The Justice Department, led by Attorney General Pam Bondi, has moved to drop the discrimination lawsuit against SpaceX, marking another reversal of Biden-era legal actions. The case, initiated in 2023, accused SpaceX of discriminating against asylum seekers and refugees by requiring job applicants to be U.S. citizens or permanent residents. Prosecutors claimed the hiring policy unlawfully discouraged qualified candidates from applying.

The DOJ’s decision to withdraw the case follows a judge’s earlier skepticism about the department’s authority to pursue the claims. No official reason for the withdrawal was provided, and neither Musk, SpaceX, nor the DOJ have issued public statements on the development.

Elon Musk was outspoken in his criticism of the lawsuit, labeling it as a politically motivated attack. Musk argued that SpaceX was repeatedly informed that hiring non-permanent residents would violate international arms trafficking laws, exposing the company to potential criminal penalties. He accused the Biden-era DOJ of weaponizing the case for political purposes.

The decision to drop the lawsuit coincides with Musk’s growing influence within the Trump administration, where he leads the Department of Government Efficiency (DOGE). Under his leadership, DOGE has implemented aggressive cost-cutting measures across federal agencies, including agencies that previously investigated SpaceX. The Federal Aviation Administration (FAA), which proposed fining SpaceX $633,000 for license violations in 2023, is currently under review by DOGE officials embedded within the agency.

Meanwhile, SpaceX’s regulatory challenges appear to be easing. A Texas-based environmental group recently dropped a separate lawsuit accusing the company of water pollution at its launch site near Brownsville. The withdrawal of the DOJ lawsuit signals a significant victory for Musk as he continues to navigate regulatory scrutiny while advancing his business ventures under the Trump administration.

Continue Reading

Business

PepsiCo joins growing list of companies tweaking DEI policies

Published on

MXM logo MxM News

Quick Hit:

PepsiCo is the latest major U.S. company to adjust its diversity, equity, and inclusion (DEI) policies as 47th President Donald Trump continues his campaign to end DEI practices across the federal government and private sector. The company is shifting away from workforce representation goals and repurposing its DEI leadership, signaling a broader trend among American corporations.

Key Details:

  • PepsiCo will end DEI workforce representation goals and transition its chief DEI officer to focus on associate engagement and leadership development.

  • The company is introducing a new “Inclusion for Growth” strategy as its five-year DEI plan concludes.

  • PepsiCo joins other corporations, including Target and Alphabet-owned Google, in reconsidering DEI policies following Trump’s call to end “illegal DEI discrimination and preferences.”

Diving Deeper:

PepsiCo has announced significant changes to its DEI initiatives, aligning with a growing movement among U.S. companies to revisit diversity policies amid political pressure. According to an internal memo, the snacks and beverages giant will no longer pursue DEI workforce representation goals. Instead, its chief DEI officer will transition to a broader role that focuses on associate engagement and leadership development. This shift is part of PepsiCo’s new “Inclusion for Growth” strategy, set to replace its expiring five-year DEI plan.

The company’s decision to reevaluate its DEI policies comes as President Donald Trump continues his push against DEI practices, urging private companies to eliminate what he calls “illegal DEI discrimination and preferences.” Trump has also directed federal agencies to terminate DEI programs and has warned that academic institutions could face federal funding cuts if they continue with such policies.

PepsiCo is not alone in its reassessment. Other major corporations, including Target and Google, have also modified or are considering changes to their DEI programs. This trend reflects a broader corporate response to the evolving political landscape surrounding DEI initiatives.

Additionally, PepsiCo is expanding its supplier base by broadening opportunities for all small businesses to participate, regardless of demographic categories. The company will also discontinue participation in single demographic category surveys, further signaling its shift in approach to DEI.

As companies like PepsiCo navigate these changes, the debate over the future of DEI in corporate America continues. With Trump leading a campaign against these practices, more companies may follow suit in reevaluating their DEI strategies.

Continue Reading

Trending

X